Ileus
A condition caused by the lack of intestinal PERISTALSIS or INTESTINAL MOTILITY without any mechanical obstruction. This interference of the flow of INTESTINAL CONTENTS often leads to INTESTINAL OBSTRUCTION. Ileus may be classified into postoperative, inflammatory, metabolic, neurogenic, and drug-induced.
Subtype terms (1)
More specific conditions that are subtypes of Ileus in the MeSH hierarchy.
- Intestinal Pseudo-Obstruction
25 drugs (24 approved, 1 experimental)
Drugs by status
Approved for this indication (1)
Phase 4 trials (26)
Phase 3 trials (6)
Phase 2 trials (2)
Phase 1 trials (2)
Other trials (5)
Organizations
Organization Involved with Phase 4 Indications (17)
- Merck
- Cubist
- University of Illinois
- Baqiyatallah Medical Sciences University
- Hospital Italiano de Buenos Aires
- Katholieke Universiteit Leuven
- Loyola University
- McMaster University
- Triemli Hospital
- University of Puerto Rico
- University of Rochester
- University of Bern
- University of Basel
- University of Barcelona
- Erfan Hospital
- OSF HealthCare
- The Cleveland Clinic
Organization Involved with Phase 3 Indications (11)
Organization Involved with Phase 2 Indications (18)
- Cato Research
- Helsinn
- Leading BioSciences, Inc
- Tioga Pharmaceuticals
- Tranzyme, Inc.
- Ohio State University
- Queen's University, Belfast
- Wakayama Medical University
- Mayo Clinic
- Epidemiological and Clinical Research Information Network
- University of California, San Diego
- John and Rebecca Moore's Cancer Center
- Hebrew University
- The Physicians' Services Incorporated Foundation
- RTI Health Solutions
- People's Liberation Army of China
- Tsumura and Company
- Jinlin University
Organization Involved with Phase 1 Indications (2)
Organization Involved with Other Experimental Indications (8)